"Iatrogenic acute coronary syndrome" - 59 Year old patient with adenocarcinoma of ascending colon and stenocardia while receiving adjuvant chemotherapy with 5-fluorouracil;"Das iatrogene akute Koronarsyndrom" - 59-Jähriger patient mit adenokarzinom des colon ascendens und stenokardien unter adjuvanter chemotherapie mit 5-fluorouracil

Zeitschrift fur Gastroenterologie

Volumn 44, Issue 9, 2006, Pages 975-979

  Gundling, Felix ^a,b   Fuchs, M ^a   Nowak, L ^a   Antoni, D ^a   Hoffmann, E ^a   Schepp, W ^a  

^a KLINIKUM BOGENHAUSEN   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 fluorouracil; Acute coronary syndrome; Adjuvant chemotherapy; Cardiotoxicity; Colorectal cancer

Indexed keywords

FLUOROURACIL; HEART ENZYME; OXALIPLATIN; RALTITREXED;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ACUTE CORONARY SYNDROME; ADJUVANT CHEMOTHERAPY; ADULT; ANAMNESIS; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CASE REPORT; COLON ADENOCARCINOMA; ECG ABNORMALITY; ENZYME BLOOD LEVEL; HEMICOLECTOMY; HUMAN; IATROGENIC DISEASE; THORAX PAIN; ADENOCARCINOMA; ASCENDING COLON; CHEMICALLY INDUCED DISORDER; COLON TUMOR; HEART INFARCTION; MALE; SYNDROME;

ADENOCARCINOMA; ANGINA PECTORIS; CHEMOTHERAPY, ADJUVANT; COLON, ASCENDING; COLONIC NEOPLASMS; FLUOROURACIL; HUMANS; IATROGENIC DISEASE; MALE; MYOCARDIAL INFARCTION; SYNDROME;

EID: 33749428133     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-927004     Document Type: Article

References (28)

1. Akhtar SS, Salim KP, Bano ZA. Symptomatic cardiotoxicity with high-dose 5-fluorouracil infusion: a prospective study. Oncology 1993; 50: 441-444
2. Allen A. The cardiotoxicity of chemotherapeutic drugs. Semin Oncol 1992; 19: 529-542
3. Andre T, Boni C, Mounedji-Boudiaf L et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350: 2343-2351
4. Arellano M, Malet-Martino M, Martino R et al. The anti-cancer drug 5-fluorouracil is metabolized by the isolated perfused rat liver and in rats into highly toxic fluoroacetate. Br J Cancer 1998; 77: 79-86
5. Becker K, Erckenbrecht JF, Häussinger D et al. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475-484
6. Burger AJ, Mannino S. 5-Fluorouracil-induced coronary vasospasm. Am Heart J 1987; 114: 433-436
7. Cianci G, Morelli MF, Cannita K et al. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity. Br J Cancer 2003; 88: 1507-1509
8. Cwikiel M, Zhang B, Eskilsson J et al. The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits. Scanning Microsc 1995; 9: 561-576
9. de Forni M, Malet-Martino MC, Jaillais P et al. Cardiotoxicity of high-dose continuous infusion fluorouracil: a prospective clinical study. J Clin Oncol 1992; 10: 1795-1801
10. Frickhofen N, Beck FJ, Jung B et al. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol 2002; 13: 797-801
11. Kohne CH, Thuss-Patience P, Friedrich M et al. Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity. Br J Cancer 1998; 77: 973-977
12. Labianca R, Beretta G, Clerici M et al. Cardiac toxicity of 5-fluorouracil: a study on 1083 patients. Tumori 1982; 68: 505-510
13. McKendall GR, Shurman A, Anamur M et al. Toxic cardiogenic shock associated with infusion of 5-fluorouracil. Am Heart J 1989; 118: 184-186
14. Meyer CC, Calis KA, Burke LB et al. Symptomatic cardiotoxicity associated with 5-fluorouracil. Pharmacotherapy 1997; 17: 729-736
15. Millart H, Brabant L, Lorenzato M et al. The effects of 5-fluorouracil on contractility and oxygen uptake of the isolated perfused rat heart. Anticancer Res 1992; 12: 571-576
16. Mosseri M, Fingert HJ, Varticovski L et al. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993; 53: 3028-3033
17. Oleksowicz L, Bruckner HW. Prophylaxis of 5-fluorouracil-induced coronary vasospasm with calcium channel blockers. Am J Med 1988; 85: 750-751
18. Oztop I, Gencer M, Okan T et al. Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QJ interval and dispersion in patients with gastrointestinal system cancers. Jpn J Clin Oncol 2004; 34: 262-268
19. Pottage A, Holt S, Ludgate S et al. Fluorouracil cardiotoxicity. Br Med J 1978; 1: 547
20. Rezkalla S, Kloner RA, Ensley J et al. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study. J Clin Oncol 1989; 7: 509-514
21. Robben NC, Pippas AW, Moore JO. The syndrome of 5-fluorouracil cardiotoxicity. An elusive cardiopathy. Cancer 1993; 15: 493-509
22. Roth A, Kolaric K, Popovic S. Cardiotoxicity of 5-fluorouracil. Cancer Chemother Rep 1975; 59: 1051-1052
23. Sasson Z, Morgan CD, Wang B et al. 5-Fluorouracil related toxic myocarditis: case reports and pathological confirmation. Can J Cardiol 1994; 10: 861-864
24. Schober C, Papageorgiou E, Harstrick A et al. Cardiotoxicity of 5-fluorouracil in combination with folinic acid in patients with gastrointestinal cancer. Cancer 1993; 72: 2242-2247
25. Sudhoff T, Enderle MD, Pahlke M et al. 5-Fluorouracil induces arterial vasocontractions. Ann Oncol 2004; 15: 661-664
26. Thyss A, Milano G, Schneider M et al. Circulating drug levels in patients presenting cardiotoxicity to 5-FU. Eur J Cancer Clin Oncol 1988; 24: 1675-1676
27. Van Cutsem E, Hoff PM, Blum JL et al. Incidence of cardiotoxicity with oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracil. Ann Oncol 2002; 13: 484-485
28. Weidmann B, Jansen W, Heider A et al. 5-Fluorouracil cardiotoxicity with left ventricular dysfunction under different dosing regimens. Am J Cardiol 1995; 75: 194-195